The effect of a Haemophilus influenzae type b (Hib) polyribosylribitol phosphate -tetanus toxoid conjugate vaccine (Hib/PRP-T) on oropharyngeal carriage of Hib was studied during an efficacy trial in Gambian infants. Children were vaccinated with Hib/PRP-T and diphtheria-tetanus toxoidspertussis (DTP) or DTP alone at ages 2, 3, and 4 months. Groups of 1000 children aged 1 -2 years were studied each year for 4 years. Hib was detected by production of a halo on antiserum agar plates. Carriage was significantly lower among children fully vaccinated with Hib/PRP-T given with DTP (4.4%; 95% confidence interval [CI], 3.8% -5.7%) than among children fully vaccinated with DTP alone (11.0%; 95% CI, 8.9% -13.0%) (protective effect adjusted by year Å 60%; 95% CI, 44% -72%; P õ .001). Hib carriage varied by year among nonvaccinated children. Hib conjugate vaccines are likely to produce a herd protective effect in underdeveloped communities, as recorded in Europe and the United States.
Haemophilus influenzae type b (Hib) capsular polysacchain developing countries as they are in industrialized communities. ride vaccines protect against invasive disease in older children but not against oropharyngeal colonization with Hib [1] . In
In The Gambia, West Africa, Hib carriage in children is high and of short duration. A recently conducted efficacy trial of a contrast, Hib capsular polysaccharide -protein conjugate vaccines reduce colonization by Hib, leading to a herd protective Hib -tetanus toxoid protein conjugate vaccine (Hib/PRP-T) in Gambian infants has provided an opportunity for determining effect. Thus, Hib disease has virtually disappeared from many developed countries in which Hib conjugate vaccines have been the effect of a conjugate vaccine on colonization by Hib in this developing country. introduced [2 -7] . Takala et al. [3] were the first to report that vaccination with a Hib conjugate vaccine reduced colonization by Hib in Finish children. However, control rates for carriage Subjects and Methods were obtained before the vaccination study was started. Reductions in carriage of Hib among American Indian children and countries, and colonization occurs at an earlier age and may Vaccines used for the trial were Hib/PRP-T (lot nos. S2801 and be more intensive [9, 11 -13] . Thus, it is uncertain whether S3044), 10 mg/dose, and DTP (lot nos. G5801, J0102, and K5590; Hib conjugate vaccines will be as effective at reducing carriage Pasteur Mérieux, Lyon, France). The outcome measures were protection against all invasive Hib disease, Hib pneumonia, and Hib carriage. The vaccine provided 95% protection against invasive Hib disease in children who had received three doses.
Study site. Children resident in the trial area received their received Hib vaccine plus DTP (Mantel-Haenszel x 2 test straadjusting for year of study, sex, age, area of residence, and vaccination status, the time since the last dose of vaccine was tified by year: protective effect Å 60%; 95% CI, 44% -72%; P õ .001). There was no significant difference in carriage rate not associated with the likelihood of being a carrier (change in deviance Å .06; 1 df; P ú .8). between children partially vaccinated with Hib vaccine plus DTP or DTP alone, but numbers were small.
Characteristics of Hib isolates. Detailed bacteriologic analyses were done on 376 isolates; only 1 was b-lactamaseMultivariate analysis of risk factors for carriage. A logistic regression model showed that carriage rates were indepenpositive. This isolate was also resistant to ampicillin, chloramphenicol, and tetracycline (MICs of 4.0, 8.0, and 16.0 mg/mL, dently and significantly associated with Hib vaccination status, residence in a rural area, and year of study (table 2) . A logistic respectively). Tetracycline resistance was detected in 11 of 100 isolates for which MICs were determined (MICs of 12 -32 mg/ regression model using only data from children who were in the efficacy trial gave similar results. In these analyses, after mL). Two isolates were multiply resistant; 1 was resistant to chloramphenicol, cotrimoxazole, and tetracycline (MICs of 8, ú32, and 12 mg/mL, respectively) and the other was the blactamase -positive isolate. No strains were resistant to cefotax- (0.27%).
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We have found significant changes in the prevalence of Hib between rural and urban areas. 
